 | • レポートコード：QYR9NV18210 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、非侵襲的非経口スクリーニングの世界市場について調査・分析し、非侵襲的非経口スクリーニングの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（器具、消耗品）、用途別（診断研究所、病院）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の非侵襲的非経口スクリーニング市場動向 ・主要企業別マーケットシェア ・非侵襲的非経口スクリーニングの種類別市場規模2014-2019 （器具、消耗品） ・非侵襲的非経口スクリーニングの用途別市場規模2014-2019 （診断研究所、病院） ・非侵襲的非経口スクリーニングの北米市場：主要企業・種類別/用途別市場規模 ・非侵襲的非経口スクリーニングのヨーロッパ市場：主要企業・種類別/用途別市場規模 ・非侵襲的非経口スクリーニングの中国市場：主要企業・種類別/用途別市場規模 ・非侵襲的非経口スクリーニングの日本国内市場：主要企業・種類別/用途別市場規模 ・非侵襲的非経口スクリーニングの東南アジア市場：主要企業・種類別/用途別市場規模 ・非侵襲的非経口スクリーニングのインド市場：主要企業・種類別/用途別市場規模 ・非侵襲的非経口スクリーニングの中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （GE Healthcare、Philips、Illumina、Thermo Fisher Scientific、Roche、PacBio、Perkinelmer、Qiagen、Agilent Technologies、BGI Group） ・非侵襲的非経口スクリーニングの市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). It can also detect the blood group and rhesus actor of the fetus. Some of the NIPTs currently available in the global market are MaterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others.In 2018, the global Non-invasive Parenteral Screening market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Non-invasive Parenteral Screening status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-invasive Parenteral Screening development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
GE Healthcare
Philips
Illumina
Thermo Fisher Scientific
Roche
PacBio
Perkinelmer
Qiagen
Agilent Technologies
BGI Group
Market segment by Type, the product can be split into
Instruments
Consumables
Market segment by Application, split into
Diagnostic Laboratories
Hospitals
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Non-invasive Parenteral Screening status, future forecast, growth opportunity, key market and key players.
To present the Non-invasive Parenteral Screening development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Non-invasive Parenteral Screening are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Non-invasive Parenteral Screening Market Size Growth Rate by Type (2014-2025)
1.4.2 Instruments
1.4.3 Consumables
1.5 Market by Application
1.5.1 Global Non-invasive Parenteral Screening Market Share by Application (2019-2025)
1.5.2 Diagnostic Laboratories
1.5.3 Hospitals
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Non-invasive Parenteral Screening Market Size
2.2 Non-invasive Parenteral Screening Growth Trends by Regions
2.2.1 Non-invasive Parenteral Screening Market Size by Regions (2019-2025)
2.2.2 Non-invasive Parenteral Screening Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Non-invasive Parenteral Screening Market Size by by Players
3.1.1 Global Non-invasive Parenteral Screening Revenue by by Players (2014-2019)
3.1.2 Global Non-invasive Parenteral Screening Revenue Market Share by by Players (2014-2019)
3.1.3 Global Non-invasive Parenteral Screening Market Concentration Ratio (CR5 and HHI)
3.2 Non-invasive Parenteral Screening Key Players Head office and Area Served
3.3 Key Players Non-invasive Parenteral Screening Product/Solution/Service
3.4 Date of Enter into Non-invasive Parenteral Screening Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Non-invasive Parenteral Screening Market Size by Type (2014-2019)
4.2 Global Non-invasive Parenteral Screening Market Size by Application (2014-2019)
5 North America
5.1 North America Non-invasive Parenteral Screening Market Size (2014-2019)
5.2 Non-invasive Parenteral Screening Key Players in North America
5.3 North America Non-invasive Parenteral Screening Market Size by Type
5.4 North America Non-invasive Parenteral Screening Market Size by Application
6 Europe
6.1 Europe Non-invasive Parenteral Screening Market Size (2014-2019)
6.2 Non-invasive Parenteral Screening Key Players in Europe
6.3 Europe Non-invasive Parenteral Screening Market Size by Type
6.4 Europe Non-invasive Parenteral Screening Market Size by Application
7 China
7.1 China Non-invasive Parenteral Screening Market Size (2014-2019)
7.2 Non-invasive Parenteral Screening Key Players in China
7.3 China Non-invasive Parenteral Screening Market Size by Type
7.4 China Non-invasive Parenteral Screening Market Size by Application
8 Japan
8.1 Japan Non-invasive Parenteral Screening Market Size (2014-2019)
8.2 Non-invasive Parenteral Screening Key Players in Japan
8.3 Japan Non-invasive Parenteral Screening Market Size by Type
8.4 Japan Non-invasive Parenteral Screening Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Non-invasive Parenteral Screening Market Size (2014-2019)
9.2 Non-invasive Parenteral Screening Key Players in Southeast Asia
9.3 Southeast Asia Non-invasive Parenteral Screening Market Size by Type
9.4 Southeast Asia Non-invasive Parenteral Screening Market Size by Application
10 India
10.1 India Non-invasive Parenteral Screening Market Size (2014-2019)
10.2 Non-invasive Parenteral Screening Key Players in India
10.3 India Non-invasive Parenteral Screening Market Size by Type
10.4 India Non-invasive Parenteral Screening Market Size by Application
11 Central & South America
11.1 Central & South America Non-invasive Parenteral Screening Market Size (2014-2019)
11.2 Non-invasive Parenteral Screening Key Players in Central & South America
11.3 Central & South America Non-invasive Parenteral Screening Market Size by Type
11.4 Central & South America Non-invasive Parenteral Screening Market Size by Application
12 International Players Profiles
12.1 GE Healthcare
12.1.1 GE Healthcare Company Details
12.1.2 Company Description and Business Overview
12.1.3 Non-invasive Parenteral Screening Introduction
12.1.4 GE Healthcare Revenue in Non-invasive Parenteral Screening Business (2014-2019))
12.1.5 GE Healthcare Recent Development
12.2 Philips
12.2.1 Philips Company Details
12.2.2 Company Description and Business Overview
12.2.3 Non-invasive Parenteral Screening Introduction
12.2.4 Philips Revenue in Non-invasive Parenteral Screening Business (2014-2019)
12.2.5 Philips Recent Development
12.3 Illumina
12.3.1 Illumina Company Details
12.3.2 Company Description and Business Overview
12.3.3 Non-invasive Parenteral Screening Introduction
12.3.4 Illumina Revenue in Non-invasive Parenteral Screening Business (2014-2019)
12.3.5 Illumina Recent Development
12.4 Thermo Fisher Scientific
12.4.1 Thermo Fisher Scientific Company Details
12.4.2 Company Description and Business Overview
12.4.3 Non-invasive Parenteral Screening Introduction
12.4.4 Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Business (2014-2019)
12.4.5 Thermo Fisher Scientific Recent Development
12.5 Roche
12.5.1 Roche Company Details
12.5.2 Company Description and Business Overview
12.5.3 Non-invasive Parenteral Screening Introduction
12.5.4 Roche Revenue in Non-invasive Parenteral Screening Business (2014-2019)
12.5.5 Roche Recent Development
12.6 PacBio
12.6.1 PacBio Company Details
12.6.2 Company Description and Business Overview
12.6.3 Non-invasive Parenteral Screening Introduction
12.6.4 PacBio Revenue in Non-invasive Parenteral Screening Business (2014-2019)
12.6.5 PacBio Recent Development
12.7 Perkinelmer
12.7.1 Perkinelmer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Non-invasive Parenteral Screening Introduction
12.7.4 Perkinelmer Revenue in Non-invasive Parenteral Screening Business (2014-2019)
12.7.5 Perkinelmer Recent Development
12.8 Qiagen
12.8.1 Qiagen Company Details
12.8.2 Company Description and Business Overview
12.8.3 Non-invasive Parenteral Screening Introduction
12.8.4 Qiagen Revenue in Non-invasive Parenteral Screening Business (2014-2019)
12.8.5 Qiagen Recent Development
12.9 Agilent Technologies
12.9.1 Agilent Technologies Company Details
12.9.2 Company Description and Business Overview
12.9.3 Non-invasive Parenteral Screening Introduction
12.9.4 Agilent Technologies Revenue in Non-invasive Parenteral Screening Business (2014-2019)
12.9.5 Agilent Technologies Recent Development
12.10 BGI Group
12.10.1 BGI Group Company Details
12.10.2 Company Description and Business Overview
12.10.3 Non-invasive Parenteral Screening Introduction
12.10.4 BGI Group Revenue in Non-invasive Parenteral Screening Business (2014-2019)
12.10.5 BGI Group Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Non-invasive Parenteral Screening Key Market Segments
Table Key Players Non-invasive Parenteral Screening Covered
Table Global Non-invasive Parenteral Screening Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Instruments Figures
Table Key Players of Instruments
Figuer Consumables Figures
Table Key Players of Consumables
Table Global Non-invasive Parenteral Screening Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Non-invasive Parenteral Screening Market Share by Application in 2018 & 2025
Figure Diagnostic Laboratories Case Studies
Figure Hospitals Case Studies
Figure Non-invasive Parenteral Screening Report Years Considered
Figure Global Non-invasive Parenteral Screening Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Non-invasive Parenteral Screening Market Size by Regions 2019-2025 (Million US$)
Table Global Non-invasive Parenteral Screening Market Size by Regions 2019-2025 (Million US$)
Table Global Non-invasive Parenteral Screening Market Share by Regions 2014-2019
Figure Global Non-invasive Parenteral Screening Market Share by Regions 2014-2019
Figure Global Non-invasive Parenteral Screening Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Non-invasive Parenteral Screening Revenue by by Players (2014-2019) (Million US$)
Table Global Non-invasive Parenteral Screening Market Share by by Players (2014-2019)
Figure Global Non-invasive Parenteral Screening Market Share by by Players in 2018
Table Global Non-invasive Parenteral Screening by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Non-invasive Parenteral Screening Product/Solution/Service
Table Date of Enter into Non-invasive Parenteral Screening Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Non-invasive Parenteral Screening Market Size by Type (2014-2019) (Million US$)
Table Global Non-invasive Parenteral Screening Market Size Share by Type (2014-2019)
Figure Global Non-invasive Parenteral Screening Market Size Market Share by Type (2014-2019)
Table Global Non-invasive Parenteral Screening Market Size by Application (2014-2019) (Million US$)
Table Global Non-invasive Parenteral Screening Market Size Share by Application (2014-2019)
Figure Global Non-invasive Parenteral Screening Market Size Market Share by Application (2014-2019)
Figure Global Non-invasive Parenteral Screening Revenue Market Share by Application in 2018
Figure North America Non-invasive Parenteral Screening Market Size 2014-2019 (Million US$)
Table North America Key Players Non-invasive Parenteral Screening Revenue (2018-2019) (Million US$)
Table North America Key Players Non-invasive Parenteral Screening Market Share (2018-2019)
Table North America Non-invasive Parenteral Screening Market Size by Type 2014-2019 (Million US$)
Table North America Non-invasive Parenteral Screening Market Share by Type 2014-2019
Table North America Non-invasive Parenteral Screening Market Size by Application 2014-2019 (Million US$)
Table North America Non-invasive Parenteral Screening Market Share by Application 2014-2019
Figure Europe Non-invasive Parenteral Screening Market Size 2014-2019 (Million US$)
Table Europe Key Players Non-invasive Parenteral Screening Revenue (2018-2019) (Million US$)
Table Europe Key Players Non-invasive Parenteral Screening Market Share (2018-2019)
Table Europe Non-invasive Parenteral Screening Market Size by Type 2014-2019 (Million US$)
Table Europe Non-invasive Parenteral Screening Market Share by Type 2014-2019
Table Europe Non-invasive Parenteral Screening Market Size by Application 2014-2019 (Million US$)
Table Europe Non-invasive Parenteral Screening Market Share by Application 2014-2019
Figure China Non-invasive Parenteral Screening Market Size 2014-2019 (Million US$)
Table China Key Players Non-invasive Parenteral Screening Revenue (2018-2019) (Million US$)
Table China Key Players Non-invasive Parenteral Screening Market Share (2018-2019)
Table China Non-invasive Parenteral Screening Market Size by Type 2014-2019 (Million US$)
Table China Non-invasive Parenteral Screening Market Share by Type 2014-2019
Table China Non-invasive Parenteral Screening Market Size by Application 2014-2019 (Million US$)
Table China Non-invasive Parenteral Screening Market Share by Application 2014-2019
Figure Japan Non-invasive Parenteral Screening Market Size 2014-2019 (Million US$)
Table Japan Key Players Non-invasive Parenteral Screening Revenue (2018-2019) (Million US$)
Table Japan Key Players Non-invasive Parenteral Screening Market Share (2018-2019)
Table Japan Non-invasive Parenteral Screening Market Size by Type 2014-2019 (Million US$)
Table Japan Non-invasive Parenteral Screening Market Share by Type 2014-2019
Table Japan Non-invasive Parenteral Screening Market Size by Application 2014-2019 (Million US$)
Table Japan Non-invasive Parenteral Screening Market Share by Application 2014-2019
Figure Southeast Asia Non-invasive Parenteral Screening Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Non-invasive Parenteral Screening Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Non-invasive Parenteral Screening Market Share (2018-2019)
Table Southeast Asia Non-invasive Parenteral Screening Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Non-invasive Parenteral Screening Market Share by Type 2014-2019
Table Southeast Asia Non-invasive Parenteral Screening Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Non-invasive Parenteral Screening Market Share by Application 2014-2019
Figure India Non-invasive Parenteral Screening Market Size 2014-2019 (Million US$)
Table India Key Players Non-invasive Parenteral Screening Revenue (2018-2019) (Million US$)
Table India Key Players Non-invasive Parenteral Screening Market Share (2018-2019)
Table India Non-invasive Parenteral Screening Market Size by Type 2014-2019 (Million US$)
Table India Non-invasive Parenteral Screening Market Share by Type 2014-2019
Table India Non-invasive Parenteral Screening Market Size by Application 2014-2019 (Million US$)
Table India Non-invasive Parenteral Screening Market Share by Application 2014-2019
Figure Central & South America Non-invasive Parenteral Screening Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Non-invasive Parenteral Screening Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Non-invasive Parenteral Screening Market Share (2018-2019)
Table Central & South America Non-invasive Parenteral Screening Market Size by Type 2014-2019 (Million US$)
Table Central & South America Non-invasive Parenteral Screening Market Share by Type 2014-2019
Table Central & South America Non-invasive Parenteral Screening Market Size by Application 2014-2019 (Million US$)
Table Central & South America Non-invasive Parenteral Screening Market Share by Application 2014-2019
Table GE Healthcare Company Details
Table GE Healthcare Revenue in Non-invasive Parenteral Screening Business 2014-2019 (Million US$)
Figure GE Healthcare Revenue Growth Rate in Non-invasive Parenteral Screening Business (2014-2019)
Table GE Healthcare Recent Development
Table Philips Company Details
Table Philips Revenue in Non-invasive Parenteral Screening Business 2014-2019 (Million US$)
Figure Philips Revenue Growth Rate in Non-invasive Parenteral Screening Business (2014-2019)
Table Philips Recent Development
Table Illumina Company Details
Table Illumina Revenue in Non-invasive Parenteral Screening Business 2014-2019 (Million US$)
Figure Illumina Revenue Growth Rate in Non-invasive Parenteral Screening Business (2014-2019)
Table Illumina Recent Development
Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Business 2014-2019 (Million US$)
Figure Thermo Fisher Scientific Revenue Growth Rate in Non-invasive Parenteral Screening Business (2014-2019)
Table Thermo Fisher Scientific Recent Development
Table Roche Company Details
Table Roche Revenue in Non-invasive Parenteral Screening Business 2014-2019 (Million US$)
Figure Roche Revenue Growth Rate in Non-invasive Parenteral Screening Business (2014-2019)
Table Roche Recent Development
Table PacBio Company Details
Table PacBio Revenue in Non-invasive Parenteral Screening Business 2014-2019 (Million US$)
Figure PacBio Revenue Growth Rate in Non-invasive Parenteral Screening Business (2014-2019)
Table PacBio Recent Development
Table Perkinelmer Company Details
Table Perkinelmer Revenue in Non-invasive Parenteral Screening Business 2014-2019 (Million US$)
Figure Perkinelmer Revenue Growth Rate in Non-invasive Parenteral Screening Business (2014-2019)
Table Perkinelmer Recent Development
Table Qiagen Company Details
Table Qiagen Revenue in Non-invasive Parenteral Screening Business 2014-2019 (Million US$)
Figure Qiagen Revenue Growth Rate in Non-invasive Parenteral Screening Business (2014-2019)
Table Qiagen Recent Development
Table Agilent Technologies Company Details
Table Agilent Technologies Revenue in Non-invasive Parenteral Screening Business 2014-2019 (Million US$)
Figure Agilent Technologies Revenue Growth Rate in Non-invasive Parenteral Screening Business (2014-2019)
Table Agilent Technologies Recent Development
Table BGI Group Company Details
Table BGI Group Revenue in Non-invasive Parenteral Screening Business 2014-2019 (Million US$)
Figure BGI Group Revenue Growth Rate in Non-invasive Parenteral Screening Business (2014-2019)
Table BGI Group Recent Development
Table Global Non-invasive Parenteral Screening Market Size by Regions (Million US$) 2019-2025
Figure Global Non-invasive Parenteral Screening Market Size Share by Regions (2019-2025)
Figure Global Non-invasive Parenteral Screening Market Size Share by Regions in 2025
Figure North America Non-invasive Parenteral Screening Market Size Forecast (2019-2025)(Million USD)
Figure Europe Non-invasive Parenteral Screening Market Size Forecast (2019-2025)(Million USD)
Figure China Non-invasive Parenteral Screening Market Size Forecast (2019-2025)(Million USD)
Figure Japan Non-invasive Parenteral Screening Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Non-invasive Parenteral Screening Market Size Forecast (2019-2025)(Million USD)
Figure India Non-invasive Parenteral Screening Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Non-invasive Parenteral Screening Market Size Forecast (2019-2025)(Million USD)
Table Global Non-invasive Parenteral Screening Market Size by Product (2019-2025) (Million US$)
Figure Global Non-invasive Parenteral Screening Market Size by Product (2019-2025)
Figure Global Non-invasive Parenteral Screening Market Size by Product in 2025
Table Global Non-invasive Parenteral Screening Market Size by Application (2019-2025) (Million US$)
Figure Global Non-invasive Parenteral Screening Market Size by Application (2019-2025)
Figure Global Non-invasive Parenteral Screening Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
非侵襲的非経口スクリーニングのグローバル市場：規模・現状・予測2019-2025 Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), t…- 世界の非侵襲的非経口スクリーニング器具産業調査2019-2025 Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), t…
- 世界の非侵襲的非経口スクリーニング器具産業調査2019-2025 Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), t…
- ヘリコバクターピロリ用非侵襲性検査のグローバル市場：規模・現状・予測2019-2025 In 2018, the global Helicobacter Pylori Non-Invasive Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Helicobacter Pylori Non-Invasive Testing status, future forecast, growth o…
- ヘリコバクターピロリ用非侵襲性検査のグローバル市場：規模・現状・予測2019-2025 In 2018, the global Helicobacter Pylori Non-Invasive Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Helicobacter Pylori Non-Invasive Testing status, future forecast, growth o…